Gareth Sheridan announced his presidential nomination in Ireland while serving as CEO of Nutriband Inc., whose product AVERSA Fentanyl also had an FDA meeting request.
2 reports, 1 independent
Updated Aug 11
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 0%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Gareth Sheridan announced his presidential nomination in Ireland while serving as CEO of Nutriband Inc., whose product AVERSA Fentanyl also had an FDA meeting request.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Nutriband Inc., led by CEO Gareth Sheridan, announced plans to scale up manufacturing of its AVERSA Fentanyl product with Kindeva and target FDA approval.Sub-event
Gareth Sheridan announced his presidential nomination in Ireland while serving as CEO of Nutriband Inc., whose product AVERSA Fentanyl also had an FDA meeting request.1 source
FDA granted meeting for AVERSA Fentanyl; Nutriband partners with Kindeva.1 source
Keep exploring
The entities involved
-
Gareth Sheridan
Irish entrepreneur and businessman
Nothing else this week.
-
Ireland
sovereign state in Northwestern Europe
- FDA
Coverage
Newest first; wire copies grouped- GlobeNewswireNutriband CEO Gareth Sheridan Seeks Nomination in Upcoming Irish Presidential Election Sheridan will temporarily step aside as CEO to enter the Irish Presidential Election. Company Chairman and Presi
- GlobeNewswireFDA Grants Nutriband Meeting Request for Aversa™ Fentanyl Abuse Deterrent Fentanyl Patch FDA grants meeting for AVERSA™ FENTANYL (abuse deterrent transdermal system) to provide feedback on the Chemis